Isbn: 9781466555464 - patient-focused network integration in biopharma: strategic imperatives for the years ahead (6 Ergebnisse)

ISBN
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (6)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

  • Sprache: Englisch

    Verlag: CRC Press, 2013

    1466555467 / 9781466555464

    • Hardcover

    Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USARomtrade Corp.

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 68,99

     Versand gratis 
    Versand innerhalb von USA

    Anzahl: 1 verfügbar

    Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

  • Sprache: Englisch

    Verlag: Taylor and Francis, 2013

    1466555467 / 9781466555464

    • Hardcover

    Anbieter: PBShop.store US, Wood Dale, IL, USAPBShop.store US

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 90,46

     Versand gratis 
    Versand innerhalb von USA

    Anzahl: 1 verfügbar

    HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

  • Sprache: Englisch

    Verlag: Taylor & Francis Group, 2013

    1466555467 / 9781466555464

    • Hardcover

    Anbieter: Biblios, frankfurt am main, HESSE, DeutschlandBiblios

    Verkäufer/-in mit 4 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Gebraucht

    EUR 84,64

    EUR 9,95 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Zustand: Used. pp. 264.

  • Sprache: Englisch

    Verlag: Taylor and Francis, 2013

    1466555467 / 9781466555464

    • Hardcover

    Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes KönigreichPBShop.store UK

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 97,54

    EUR 4,85 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 1 verfügbar

    HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

  • Sprache: Englisch

    Verlag: CRC Pr I Llc, 2013

    1466555467 / 9781466555464

    • Hardcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 118,06

    EUR 11,66 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 1 verfügbar

    Hardcover. Zustand: Brand New. 1st edition. 183 pages. 9.50x6.50x0.75 inches. In Stock.

  • Sprache: Englisch

    Verlag: Taylor & Francis Inc Jun 2013, 2013

    1466555467 / 9781466555464

    • Hardcover

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 109,45

    EUR 30,50 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Buch. Zustand: Neu. Neuware - The biopharmaceutical industry as we know it today is going through a massive upheaval as a result of the uncertainty of healthcare reform and increasing regulatory pricing pressure. A wake-up call to all sectors of the healthcare value chain, Patient-Focused Network Integration in BioPharma: Strategic Imperatives for the Years Ahead explores patient-focused network integration as quite possibly the only way for organizational evolution to occur. The book discusses how to align enterprises with the patient at the center. It details the historical context of the biopharmaceutical value chain and the current set of challenges facing the industry, and then details the author's unique and sustainable agenda for change. The book traces the critical but often ignored relationships between hospitals, insurance companies, biopharma manufacturers, government regulators, and clinical scientists. For too long, these parties have been operating in a void, without recognizing the interconnectedness of their objectives, even though these objectives are often competing and misaligned.This book points out the gaps that exist and develops a set of recommendations regarding disease treatments, clinical development of new products, and collaboration between these players that can result in a sustainable solution to the healthcare mess. Each chapter can be viewed as an independent essay, in that it deals with a specific dimension of the healthcare value chain. However, together they provide an integrated discussion on how to begin the task of creating an integrated value chain network for healthcare. The book begins with the patient, and then works its way back down the value chain, all the way to the drug development and clinical trials stage of the value chain. The common thread throughout the chapters is the emphasis on collaboration, strategic alignment, and a focus on delivering value to the end patient. Very simply, all parties in the healthcare value chain network must align their strategic planning to derive innovation solutions. It is only through true collaboration and aligned thinking that the parties in the drug development, distribution, insurance payors, and hospital provider network can deal with the incredible complexity and massive challenges that face the industry. The book provides a compelling maturity model that enables readers to gauge the level of network integration their enterprise is at today, and where they need to move in the future.